Investigating the association between incretin-based therapies and thyroid cancer incidence among US Medicare beneficiaries with diabetes
{{output}}
Introduction: Preclinical studies suggest a potential link between glucagon-like peptide 1 receptor agonists (GLP-1RA) and thyroid cancer (TC), yet it is unclear if this risk translates to humans. ... ...
